Dr Catherine Vickers Johnson, AUD, CCC-A | |
107 Regional Rehabiliation Center, Florida State University, Tallahassee, FL 32306 | |
(850) 645-7303 | |
Not Available |
Full Name | Dr Catherine Vickers Johnson |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 107 Regional Rehabiliation Center, Tallahassee, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215027685 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | AY1287 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Catherine Vickers Johnson, AUD, CCC-A 2420 Shalley Dr, Tallahassee, FL 32309-3019 Ph: (850) 893-5720 | Dr Catherine Vickers Johnson, AUD, CCC-A 107 Regional Rehabiliation Center, Florida State University, Tallahassee, FL 32306 Ph: (850) 645-7303 |
News Archive
Pediatric cardiology researchers and clinicians from numerous centers from around the world are gathering at the Cardiology 2015: the 18th Annual Update on Pediatric and Congenital Cardiovascular Disease conference, sponsored by The Children's Hospital of Philadelphia and Phoenix Children's Hospital on Feb. 11 to Feb. 15 in Scottsdale, Ariz.
Triphase Accelerator Corporation today announced that marizomib, its novel, potent proteasome inhibitor, has been granted orphan drug designation by the U.S. Food and Drug Administration's Office of Orphan Products Development for the treatment of multiple myeloma. The orphan drug designation will provide Triphase with 7-year marketing exclusivity for marizomib and other benefits upon FDA approval.
Youths who receive more than 10 pounds a week in spending money and who buy alcohol for themselves are more likely to become 'problem drinkers', a survey of over 10,000 teenagers reveals.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase II protocol for the clinical study of Archexin as a treatment of ovarian cancer to the U.S. Food and Drug Administration (FDA).
› Verified 6 days ago
Dr. Sarah Rene Hamman, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1818 Miccosukee Commons Dr, Ste. 1, Tallahassee, FL 32308 Phone: 850-553-4327 | |
Dr. Ronald James Fryk, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1607 Saint James Ct, Tallahassee, FL 32308 Phone: 850-521-5772 | |
Mrs. Janet S. Kahn, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 107 Regional Rehabilitation Center, Tallahassee, FL 32306 Phone: 850-645-4880 Fax: 850-644-8994 | |
Ann E Hennessy, M.A. CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1500 Apalachee Pkwy, Tallahassee, FL 32301 Phone: 850-942-4007 Fax: 850-942-7927 | |
Miracle Ear Audiologist Medicare: Not Enrolled in Medicare Practice Location: 900 Capital Cir Se Ste 1, Tallahassee, FL 32301 Phone: 850-942-4007 Fax: 850-942-7927 | |
Richard Larrimore Johnson Iii, M.S., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1607 Saint James Ct, Tallahassee, FL 32308 Phone: 850-878-0191 |